SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001140361-20-005628
Filing Date
2020-03-12
Accepted
2020-03-12 17:01:11
Documents
14
Period of Report
2020-05-19

Document Format Files

Seq Description Document Type Size
1 PRE 14A nc10007562x1_pre14a.htm PRE 14A 1905843
2 coachtemplate_chair.jpg GRAPHIC 3606
3 coachtemplate_check.jpg GRAPHIC 3627
4 coachtemplate_ex.jpg GRAPHIC 3461
5 coachtemplate_member.jpg GRAPHIC 3468
6 logo_footerprothena.jpg GRAPHIC 6866
7 logo_prothena.jpg GRAPHIC 18202
8 nc10007562x1_pc01.jpg GRAPHIC 1367897
9 nc10007562x1_pc02.jpg GRAPHIC 1442757
10 nc10007562x1_piecharts1.jpg GRAPHIC 106312
11 prothena_chairdark.jpg GRAPHIC 3738
12 prothena_checkdark.jpg GRAPHIC 3824
13 prothena_exdark.jpg GRAPHIC 3567
14 prothena_memberdark.jpg GRAPHIC 3539
  Complete submission text file 0001140361-20-005628.txt   5809840
Mailing Address 77 SIR JOHN ROGERSON'S QUAY, BLOCK C GRAND CANAL DOCKLANDS DUBLIN 2 L2 D02 T804
Business Address 77 SIR JOHN ROGERSON'S QUAY, BLOCK C GRAND CANAL DOCKLANDS DUBLIN 2 L2 D02 T804 011-353-1-236-2500
Prothena Corp plc (Filer) CIK: 0001559053 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-35676 | Film No.: 20709616
SIC: 2834 Pharmaceutical Preparations